This week’s episode will be focusing on one of the Non-Hodgkin Lymphomas: Follicular Lymphoma. We will go over the important details on diagnostic criteria, indications for treatment and treatment options.
Jun 29
Transitioning from Fellow to Attending with Dr. Laura Vater
This week’s episode we have a very special guest, friend and colleague Dr. Laura Vater joining us to talk about one of the biggest transitions in medicine—moving from fellow to attending.Dr Vater is a GI oncologist at IU, writer, and speaker. She focuses on the dignity of patient ... Show More
19m 7s
Sep 2025
Episode 138: Follicular Lymphoma Series, Pt 3 - Relapsed/Refractory Management (non-cellular therapy options)
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>This week, we shift our focus to talking about relapsed/refractory follicular lymphoma. In this episode, we will specifically discuss treatment options other than cellular therapy, which will be an u ... Show More
29m 51s
May 2025
Episode 136: Follicular Lymphoma Series, Pt. 1 - Introduction
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">This week, we kick off a new series, this time focusing on follicular lymphoma! This series will build on a lot of fundamentals that we discussed in our prior series. In this first episode, we start with an ... Show More
25m 58s
Jun 2025
Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">This week, we continue our conversation on follicular lymphoma, this time focusing on front line therapy. We discuss how we approach localized and diffuse disease and the data behind why we do what we do. </ ... Show More
30m 11s
Sep 2025
Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ... Show More
36m 11s
Oct 2023
Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)
<p class="" style="white-space:pre-wrap;">This week, we pick up on our discussion about management of DLBCL, focusing on the primary refractory setting. A big part of this discussion is the role of CAR-T therapy. If you have not done so already, we highly recommend you check out ... Show More
35m 55s
<p class="" style="white-space:pre-wrap;">This week, we continue our conversation about DLBCL, this time focusing our attention on the management of early stage disease. </p><p class="" style="white-space:pre-wrap;">In this week’s episode, we delve into the management of advance ... Show More